Today: September 20, 2018, 3:20 pm
  
Business

QIAGEN Partners with U.K. to Expand Biomarker Research in Manchester

PR-Inside.com: 2018-07-11 13:01:03

Public-private alliances will create world-leading genomics campus and accelerate commercialization

QIAGEN Partners with U.K. to Expand Biomarker Research in Manchester

QIAGEN
Investor Relations
John Gilardi
+49 2103 29 11711
or
Sarah Fakih
+49 2103 29 11457
e-mail:ir@QIAGEN.com
or
Public Relations
Robert Reitze
+49 2103 29 11676
e-mail: pr@QIAGEN.com

QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced a partnership with multiple organizations to support creating a global genomics campus in Manchester, U.K., for innovation, life sciences, translational science and molecular diagnostics. QIAGEN is working with Health Innovation Manchester, the partnership which brings together the region’s entire spectrum of public, academic and clinical resources to develop a world-leading genomics campus in the heart of Manchester’s health innovation district, anchored by QIAGEN’s European Centre of Excellence for Precision Medicine and hub for diagnostics development.

“This is a hugely important step change for Greater Manchester's already strong life sciences sector. The new health innovation campus, with QIAGEN at its heart, will support the continued growth of businesses which are driving the future shape of medicine and health care, and cement our position as a world-leader in precision medicine,” said Rowena Burns, Chair of Health Innovation Manchester and Manchester Science Partnerships. “This is precisely what Health Innovation Manchester was set up to do, and combined with our devolved health and social care system, places us in an incredibly strong position to address the health challenges of the population.”

“These partnerships leverage QIAGEN’s rich expertise in Manchester to accelerate innovation as a basis for the development of valuable molecular tests. This is a true win-win situation, bringing together QIAGEN, the global leader in Sample to Insight solutions, with important intellectual assets in the U.K. to accelerate molecular biomarker research and subsequent development of new and promising diagnostic assays,” said Peer M. Schatz, Chief Executive Officer of QIAGEN. “We expect this collaborative initiative to serve as an innovation incubator to support translating genomic biomarkers into clinical use and ultimately to yield benefits for our customers and patients everywhere who need advanced diagnostic insights.”

The full press release can be found here

###

QIAGEN partners with U.K. to expand biomarker research in Manchester

Press Information


Published by
Hossam Abdel-Kader
+43 1 9582319
e-mail
http://www.pr-inside.com/


# 416 Words
Related Articles
More From The Author
Bavarian Nordic Announces Initiation of Phase 2 [..]
Investigator-led study has commenced dosing Immunotherapy candidate CV301 is being assessed in combination with checkpoint inhibitors [..]
One Month to Deadline for Zayed Sustainability [..]
With just one month to go until the August 9 deadline, the Zayed Sustainability Prize today issued a call for [..]
EURid, the .eu Registry, Supports Clean Water [..]
EURid, the .eu and .ею registry manager, is supporting the Ugandan Borehole project to offset its CO2 emissions generated in [..]
Inviqa Acquires Webcredible to Grow UX Capabilities
Digital consultancy company Inviqa today acquired experience design agency Webcredible to expand its customer and user experience capabilities [..]
DE-CIX Launches ‘Project Reach’ with Bandwidth Infrastructure [..]
DE-CIX, the world’s leading Internet Exchange operator, today announced the launch of ‘Project Reach’, together with its [..]
 
More From Business
InSitu Asia sells coworking space “District6” to [..]
InSitu Asia has sold co-working space District6 to Zero Ten, headquartered in Fukuoka City, Hakata-ku. InSitu Asia Co-Founder Yuta [..]
Hong Kong Export Index 3Q18: Exporters Advised [..]
HONG KONG, Sept 18, 2018 - (ACN Newswire) - Hong Kong exporters are urged to diversify into emerging markets such [..]
Coinsuper CEO Bullish on long-term Crypto at [..]
HONG KONG, Sept 17, 2018 - (ACN Newswire) - Coinsuper Co-founder & CEO, Karen Chen, was invited as the speaker [..]
Coinsuper CEO Bullish on long-term Crypto at [..]
HONG KONG, Sept 17, 2018 - (ACN Newswire) - Coinsuper Co-founder & CEO, Karen Chen, was invited as the speaker [..]
Demand for Tarps Surges in Preparation for [..]
With more than 1 million people now bracing for the Hurricane Florence and the mandatory evacuation in coastal areas that [..]

Disclaimer: If you have any questions regarding information in this press release please contact the company added in the press release. Please do not contact pr-inside. We will not be able to assist you. PR-inside disclaims the content included in this release.